1.865 USD
+0.04 (+2.47%)
CSTE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 41 industry peers in the Building Products industry. While CSTE seems to be doing ok healthwise, there are quite some concerns on its profitability. CSTE is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CSTE has reported negative net income.
CSTE had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CSTE reported negative net income in multiple years.
Of the past 5 years CSTE 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -13.97%, CSTE is doing worse than 80.49% of the companies in the same industry.
With a Return On Equity value of -30.04%, CSTE is not doing good in the industry: 80.49% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.97% | ||
| ROE | -30.04% | ||
| ROIC | N/A |
ROA(3y)-11.12%
ROA(5y)-6.06%
ROE(3y)-20.4%
ROE(5y)-11.19%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CSTE's Gross Margin of 19.38% is on the low side compared to the rest of the industry. CSTE is outperformed by 73.17% of its industry peers.
In the last couple of years the Gross Margin of CSTE has declined.
CSTE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 19.38% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.44%
GM growth 5Y-4.33%
2. Health
2.1 Basic Checks
CSTE does not have a ROIC to compare to the WACC, probably because it is not profitable.
CSTE has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, CSTE has more shares outstanding
The debt/assets ratio for CSTE has been reduced compared to a year ago.
2.2 Solvency
CSTE has an Altman-Z score of 1.32. This is a bad value and indicates that CSTE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CSTE (1.32) is worse than 92.68% of its industry peers.
CSTE has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, CSTE belongs to the top of the industry, outperforming 92.68% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.32 |
ROIC/WACCN/A
WACC8.42%
2.3 Liquidity
CSTE has a Current Ratio of 2.07. This indicates that CSTE is financially healthy and has no problem in meeting its short term obligations.
CSTE's Current ratio of 2.07 is fine compared to the rest of the industry. CSTE outperforms 60.98% of its industry peers.
A Quick Ratio of 1.36 indicates that CSTE should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.36, CSTE is in the better half of the industry, outperforming 63.41% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.07 | ||
| Quick Ratio | 1.36 |
3. Growth
3.1 Past
The earnings per share for CSTE have decreased strongly by -73.42% in the last year.
CSTE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.45%.
Measured over the past years, CSTE shows a decrease in Revenue. The Revenue has been decreasing by -4.09% on average per year.
EPS 1Y (TTM)-73.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
Revenue 1Y (TTM)-15.45%
Revenue growth 3Y-11.71%
Revenue growth 5Y-4.09%
Sales Q2Q%-5.13%
3.2 Future
Based on estimates for the next years, CSTE will show a small growth in Earnings Per Share. The EPS will grow by 3.55% on average per year.
The Revenue is expected to decrease by -2.34% on average over the next years.
EPS Next Y-66.05%
EPS Next 2Y-8.91%
EPS Next 3Y3.55%
EPS Next 5YN/A
Revenue Next Year-10.85%
Revenue Next 2Y-4.83%
Revenue Next 3Y-2.34%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CSTE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CSTE. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.91%
EPS Next 3Y3.55%
5. Dividend
5.1 Amount
No dividends for CSTE!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:CSTE (12/8/2025, 2:04:53 PM)
1.865
+0.04 (+2.47%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)
Earnings (Next)
Inst Owners27.96%
Inst Owner Change-9.11%
Ins Owners1.65%
Ins Owner ChangeN/A
Market Cap64.47M
Revenue(TTM)400.66M
Net Income(TTM)-70.09M
Analysts82.86
Price Target4.08 (118.77%)
Short Float %0.65%
Short Ratio0.48
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-57.48%
Min EPS beat(2)-79.74%
Max EPS beat(2)-35.23%
EPS beat(4)1
Avg EPS beat(4)-38.25%
Min EPS beat(4)-79.74%
Max EPS beat(4)11.15%
EPS beat(8)3
Avg EPS beat(8)-28.89%
EPS beat(12)3
Avg EPS beat(12)-233.01%
EPS beat(16)4
Avg EPS beat(16)-183.76%
Revenue beat(2)1
Avg Revenue beat(2)-2.34%
Min Revenue beat(2)-7.26%
Max Revenue beat(2)2.57%
Revenue beat(4)2
Avg Revenue beat(4)-1.89%
Min Revenue beat(4)-7.26%
Max Revenue beat(4)2.57%
Revenue beat(8)3
Avg Revenue beat(8)-4.15%
Revenue beat(12)3
Avg Revenue beat(12)-5.84%
Revenue beat(16)4
Avg Revenue beat(16)-4.38%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-35.71%
EPS NQ rev (3m)-35.71%
EPS NY rev (1m)-16.67%
EPS NY rev (3m)-16.67%
Revenue NQ rev (1m)1.85%
Revenue NQ rev (3m)1.85%
Revenue NY rev (1m)1.59%
Revenue NY rev (3m)1.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.16 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.28 | ||
| P/tB | 0.28 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.37
EYN/A
EPS(NY)-1.02
Fwd EYN/A
FCF(TTM)-1.2
FCFYN/A
OCF(TTM)-0.9
OCFYN/A
SpS11.59
BVpS6.75
TBVpS6.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.97% | ||
| ROE | -30.04% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 19.38% | ||
| FCFM | N/A |
ROA(3y)-11.12%
ROA(5y)-6.06%
ROE(3y)-20.4%
ROE(5y)-11.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.44%
GM growth 5Y-4.33%
F-Score2
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 71.22% | ||
| Cap/Sales | 2.6% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.07 | ||
| Quick Ratio | 1.36 | ||
| Altman-Z | 1.32 |
F-Score2
WACC8.42%
ROIC/WACCN/A
Cap/Depr(3y)49.02%
Cap/Depr(5y)60.64%
Cap/Sales(3y)2.3%
Cap/Sales(5y)3.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
EPS Next Y-66.05%
EPS Next 2Y-8.91%
EPS Next 3Y3.55%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.45%
Revenue growth 3Y-11.71%
Revenue growth 5Y-4.09%
Sales Q2Q%-5.13%
Revenue Next Year-10.85%
Revenue Next 2Y-4.83%
Revenue Next 3Y-2.34%
Revenue Next 5YN/A
EBIT growth 1Y-69.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1.38%
EBIT Next 3Y24.13%
EBIT Next 5YN/A
FCF growth 1Y-201.95%
FCF growth 3YN/A
FCF growth 5Y-18.43%
OCF growth 1Y-157.02%
OCF growth 3Y15.48%
OCF growth 5Y-17.42%
CAESARSTONE LTD / CSTE FAQ
What is the ChartMill fundamental rating of CAESARSTONE LTD (CSTE) stock?
ChartMill assigns a fundamental rating of 2 / 10 to CSTE.
What is the valuation status for CSTE stock?
ChartMill assigns a valuation rating of 0 / 10 to CAESARSTONE LTD (CSTE). This can be considered as Overvalued.
What is the profitability of CSTE stock?
CAESARSTONE LTD (CSTE) has a profitability rating of 1 / 10.
What is the expected EPS growth for CAESARSTONE LTD (CSTE) stock?
The Earnings per Share (EPS) of CAESARSTONE LTD (CSTE) is expected to decline by -66.05% in the next year.
Can you provide the dividend sustainability for CSTE stock?
The dividend rating of CAESARSTONE LTD (CSTE) is 0 / 10 and the dividend payout ratio is 0%.